Vance tours Eli Lilly pharmaceutical plant in Indianapolis

Vice President JD Vance toured an Eli Lilly pharmaceutical manufacturing facility in Indianapolis, Indiana on Feb. 18, 2026, highlighting domestic drug production as part of the administration's prescription drug cost agenda. The visit came as the administration's executive order on drug price transparency in Medicare had taken effect; Vance cited Lilly's voluntary insulin price reductions as evidence that market-based reform could lower drug costs without government price setting.